Lung cancer research registry for treatment and outcomes
Part of Cancer, Lungs & breathing clinical trials.
This study collects information from people with lung cancer to understand how different treatments work and what outcomes they have. It includes patients with non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) at various stages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able to understand and sign a consent form and fill out questionnaires.
- You need a confirmed diagnosis of non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC).
- For the main project: you must have stage IV NSCLC and start systemic therapy (like chemotherapy or immunotherapy) within 4 weeks of signing consent.
- For the satellite projects: you can have NSCLC stage I-III or SCLC, and you must sign consent within 4 weeks of starting your first cancer treatment (surgery, radiation, or chemotherapy). If your first treatment is surgery, you have up to 3 months after surgery to sign.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with lung cancer over time to see how the disease changes, especially during and after treatment. By collecting tumor samples and blood tests every few months, researchers hope to understand why some cancers come back or become resistant, and find better ways to treat them.
This trial is a registry that collects information from people with certain types and stages of lung cancer. It helps researchers understand how these cancers are managed in real life, which can guide better future care.
This study looks at how tumor and blood biomarker results can guide treatment for people with non-small cell lung cancer (NSCLC). Depending on the cancer stage, it may follow standard-of-care treatment plans around surgery or first-line immunotherapy.
This study collects blood and tissue samples from people with non-small cell lung cancer (NSCLC) either before or after treatment. It aims to help researchers learn more about how tumors respond, especially in cancers with specific genetic changes or after certain pre-surgery therapies.
This trial does not test a new drug. It looks at existing medical records to compare how well different treatments work for people with advanced non-small cell lung cancer. You may be eligible if your cancer is advanced and you are not in another clinical trial.
This study is looking back at the medical records of people with early-stage non-small cell lung cancer who had surgery or radiation therapy between 2018 and 2019. The goal is to understand how patients were diagnosed and treated, which may help improve care for others in the future.
Hear when a new Non Small Cell Lung Cancer Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.